R Squared’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$625K Sell
9,963
-20,754
-68% -$1.66M 0.34% 70
2025
Q4
$2.93M Sell
30,717
-316
-1% -$31K 1.37% 7
2025
Q3
$3.03M Buy
31,033
+15,677
+102% +$1.62M 1.3% 2
2025
Q2
$1.65M Buy
15,356
+7,826
+104% +$792K 0.91% 13
2025
Q1
$760K Buy
7,530
+7,440
+8,267% +$749K 0.81% 17
2024
Q4
$8.04K Buy
+90
New +$7.92K 0.01% 1204

Other funds holding BSX

R Squared's BSX Position: Q1 2026 in Review

R Squared reduced its Boston Scientific (BSX) stake by 68% in Q1 2026, selling an estimated $1.66M and leaving 9,963 shares worth $625K. The position accounts for 0.34% of the portfolio, ranked #70.

R Squared first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.03M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • R Squared held 9,963 shares of Boston Scientific worth $625K as of Q1 2026.
  • R Squared sold 20,754 Boston Scientific shares in Q1 2026, an estimated $1.66M.
  • Boston Scientific made up 0.34% of R Squared's portfolio in Q1 2026, its #70 holding.
  • R Squared first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • R Squared's Boston Scientific position peaked at $3.03M in Q3 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.